Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases

Yinghan Chan; Ronan Macloughlin; Flavia C Zacconi; Murtaza M Tambuwala; Ritesh M Pabari; Sachin Kumar Singh; Terezinha De Jesus Andreoli Pinto; Gaurav Gupta; Dinesh Kumar Chellappan; Kamal Dua

doi:10.2217/nnm-2021-0087

Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases

Yinghan Chan, Ronan Macloughlin, Flavia C Zacconi, Murtaza M Tambuwala, Ritesh M Pabari, Sachin Kumar Singh, Terezinha De Jesus Andreoli Pinto, Gaurav Gupta, Dinesh Kumar Chellappan, Kamal Dua

Research output: Contribution to journal › Comment/debate › peer-review

6 Citations (Scopus)

56 Downloads (Pure)

Abstract

“Nanomaterials offer great prospects to be developed as advanced and versatile drug
delivery platforms targeting PI3K signaling in the treatment of chronic respiratory diseasess owing to their unique physicochemical properties, at the same time, having shown to improve the pharmacokinetics of existing therapeutics.”

Original language	English
Pages (from-to)	1351-1355
Number of pages	5
Journal	NANOMEDICINE
Volume	16
Issue number	16
Early online date	17 May 2021
DOIs	https://doi.org/10.2217/nnm-2021-0087
Publication status	Published (in print/issue) - Jul 2021

Keywords

nanomaterial
drug delivery
formulation
respiratory diseases
chronic respiratory disease
nanomaterials
phosphoinositide 3-kinase

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/nnm-2021-0087

nnm-2021-0087Final published version, 1.4 MBLicence: CC BY

Cite this

@article{3013e03a19164f31a7523a4070f29aae,

title = "Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases",

abstract = "“Nanomaterials offer great prospects to be developed as advanced and versatile drugdelivery platforms targeting PI3K signaling in the treatment of chronic respiratory diseasess owing to their unique physicochemical properties, at the same time, having shown to improve the pharmacokinetics of existing therapeutics.”",

keywords = "nanomaterial, drug delivery, formulation, respiratory diseases, chronic respiratory disease, nanomaterials, phosphoinositide 3-kinase",

author = "Yinghan Chan and Ronan Macloughlin and Zacconi, {Flavia C} and Tambuwala, {Murtaza M} and Pabari, {Ritesh M} and Singh, {Sachin Kumar} and {Jesus Andreoli Pinto}, {Terezinha De} and Gaurav Gupta and Chellappan, {Dinesh Kumar} and Kamal Dua",

year = "2021",

month = jul,

doi = "10.2217/nnm-2021-0087",

language = "English",

volume = "16",

pages = "1351--1355",

journal = "NANOMEDICINE",

issn = "1743-5889",

publisher = "Future Medicine Ltd.",

number = "16",

}

TY - JOUR

T1 - Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases

AU - Chan, Yinghan

AU - Macloughlin, Ronan

AU - Zacconi, Flavia C

AU - Tambuwala, Murtaza M

AU - Pabari, Ritesh M

AU - Singh, Sachin Kumar

AU - Jesus Andreoli Pinto, Terezinha De

AU - Gupta, Gaurav

AU - Chellappan, Dinesh Kumar

AU - Dua, Kamal

PY - 2021/7

Y1 - 2021/7

N2 - “Nanomaterials offer great prospects to be developed as advanced and versatile drugdelivery platforms targeting PI3K signaling in the treatment of chronic respiratory diseasess owing to their unique physicochemical properties, at the same time, having shown to improve the pharmacokinetics of existing therapeutics.”

AB - “Nanomaterials offer great prospects to be developed as advanced and versatile drugdelivery platforms targeting PI3K signaling in the treatment of chronic respiratory diseasess owing to their unique physicochemical properties, at the same time, having shown to improve the pharmacokinetics of existing therapeutics.”

KW - nanomaterial

KW - drug delivery

KW - formulation

KW - respiratory diseases

KW - chronic respiratory disease

KW - nanomaterials

KW - phosphoinositide 3-kinase

UR - https://pubmed.ncbi.nlm.nih.gov/33998829/

UR - https://www.futuremedicine.com/doi/10.2217/nnm-2021-0087

UR - http://www.scopus.com/inward/record.url?scp=85111787621&partnerID=8YFLogxK

U2 - 10.2217/nnm-2021-0087

DO - 10.2217/nnm-2021-0087

M3 - Comment/debate

C2 - 33998829

SN - 1743-5889

VL - 16

SP - 1351

EP - 1355

JO - NANOMEDICINE

JF - NANOMEDICINE

IS - 16

ER -

Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this